🔗 Share this article TikTok Content Creators Fueling Parallel Trade for Unapproved Slimming Drug An underground market for unapproved slimming drugs is propelled by social media fitness personalities and vendors on communication apps, according to new investigations. Experimental Drug Gaining Traction Via Social Media Retatrutide, which remains in research studies, is being advertised by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to contact these profiles privately for supplier links, while also receiving discount codes. Thriving Commerce on Social Networks Separately, a flourishing trade exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and claims of next-day UK delivery. Vendors promote the drug there before redirecting customers to WhatsApp for purchases. Understanding The Experimental Drug This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic. Medical Experts Voice Concerns However, physicians and pharmacists have warned that the distribution of what remains an unapproved drug in the United Kingdom is a cause for concern and could result in individuals injecting products of uncertain source. Some professionals said the popularity for retatrutide could be linked to the increasing cost of approved weight loss treatments such as Mounjaro. Regulatory Status and Enforcement Selling retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012. Several content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still breach medicines, advertising, and consumer regulations, risking penalties, legal action or imprisonment. Service Reaction and Material Removal Based on the social media company, the service has removed problematic material and banned related hashtags and search suggestions. The company said it was dedicated to maintaining the platform safe and investing in strengthening enforcement strategies. Online Trading Activities Investigations also discovered groups with up to nine thousand members selling retatrutide using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up groups with numerous of members, populated with images of weight loss, positive reviews and detailed guides for preparing or administering at home. Within moments of joining one community, a vendor posted contact information, where most purchases occur. The vendor provided an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None inquired about weight, health issues or past usage. Product Details and Costs Within these communities, messages display dark colored packages with Royal Mail labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.” Buyers can choose between powder vials, prepared at residence with sterile water, or ready-to-use pens usually sold at 160 pounds for 20mg. When questioned how much time a pen should be used, sellers give conflicting answers varying between a few weeks to “depends on your body”. Service Oversight and Safety Measures A spokesperson for the messaging service said it regularly monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”. Healthcare Expert Cautions “Individuals are administering materials they cannot confirm. Although the science behind this drug is sound, these online products may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at a pharmacy service. A medical professional of Asda Online Doctor connected the surge in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are using online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained. Her team has previously seen patients harmed by self-injection from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These materials could be impure or improperly measured.” Manufacturer Position A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a company investigational substance not yet approved … may subject patients to possibly serious medical dangers”.